Pfizer, BioNTech And Moderna Make $65,000 Every Minute – Report - Breaking News Nigeria
Connect with us

Business News

Pfizer, BioNTech And Moderna Make $65,000 Every Minute – Report

Published

on


Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the world’s poorest countries remain largely unvaccinated, according to a new analysis.

The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People’s Vaccine Alliance (PVA), a coalition campaigning for wider access to Covid vaccines, which based its calculations on the firms’ own earning reports.

The Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a second, $65,000 a minute or $93.5 million a day.

“It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus,” Maaza Seyoum of the African Alliance and People’s Vaccine Alliance Africa said.

“Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low-income countries out in the cold.”

Pfizer and BioNTech have delivered less than one percent of their total supplies to low-income countries while Moderna has delivered just 0.2 percent, the PVA said.

Currently, 98 percent of people in low-income countries have not been fully vaccinated.

The three companies’ actions are in contrast to AstraZeneca and Johnson & Johnson, which provided their vaccines on a not-for-profit basis, though both have announced they foresee ending this arrangement in the future as the pandemic winds down.

PVA said that despite receiving public funding of more than $8 billion, Pfizer, BioNTech and Moderna have refused calls to transfer vaccine technology to producers in low- and middle-income countries via the World Health Organization, “a move that could increase global supply, drive down prices and save millions of lives.”

“In Moderna’s case, this is despite explicit pressure from the White House and requests from the WHO that the company collaborate in and help accelerate its plan to replicate the Moderna vaccine for wider production at its mRNA hub in South Africa,” the group said.

While Pfizer CEO Albert Bourla has dismissed technology transfer as “dangerous nonsense,” the WHO’s decision to grant emergency use approval to the Indian-developed Covaxin earlier this month proves that developing countries have the capacity and expertise, PVA added.

PVA, whose 80 members include the African Alliance, Global Justice Now, Oxfam, and UNAIDS, is calling for pharmaceutical corporations to immediately suspend intellectual property rights for COVID vaccines by agreeing to a proposed waiver of the World Trade Organisation’s TRIPS agreement.

More than 100 nations, including the United States, back that move, but it is being blocked by rich countries including the UK and Germany.

-AFP

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business News

Stakeholders laud NPA’s N89.9b remittance to govt coffers

Published

on


Stakeholders in the maritime sector have lauded the remittance of N89.9 billion by the Nigerian Ports Authority (NPA) into the Federal Government’s coffers.
   
Acting Managing Director, Mohammed Bello-Koko had recently said the Authority has so far remitted about N89.9 billion into government coffers this year, after about 120 percent surge in internally generated revenue.
 
Commenting on the development, the former national President, National Association of Government Approved Freight Forwarders (NAGAFF), Eugene Nweke said it is no longer in doubt that Bello-Koko has the ability to productively or prudently manage the Authority to generate enhanced revenue.
   
Nweke stressed the need for the NPA management to also focus on infrastructure maintenance and sustenance. 

A chieftain of the National Association of Road Transport Owners (NARTO), Mr Abdulhai Inua Mohammed said the figure was truly impressive.

He, however, stressed the need for Bello-Koko to look inwards, beyond revenue generation. He bemoaned infrastructural decay at the ports, and urged the NPA helmsman to do everything possible to get the infrastructure fixed.

An importer and industry expert, Bolutife Egbewole said while he didn’t expect the acting managing director to deliver so much within so short a time, the feat, nonetheless, shows that Bello-Koko knows his ‘onions’.

Continue Reading

Business News

‘Multiple products, innovation driving our growth’

Published

on


Vitafoam Nigeria Plc  has attributed its steadily impressive performance to continuous investment in innovative products and services across its businesses.

Despite the inclement operating environment, Vitafoam has remained resilient with an average gross margin of 37.90 per cent in the last five years and the company’s shares is one of the most sought after on the Nigerian Exchange Limited (NGX) due to track record of consistent profitability.

Group Managing  Director, Vitafoam Nigeria Plc, Mr Taiwo Adeniyi, explained that Vitafoam was no longer just  about manufacturing of rigid foams but had developed other innovative products through its subsidiaries in Nigeria and overseas.

He spoke during their facilities tour of Vitapur’s plant in Lagos by members of  Organisation for Technology Advancement of Cold Chain in West Africa {OTACCWA) and Nigerian Institute of Architects (NIA).

“Vitafoam is consolidating into core business with the introduction of innovative value added products and services. The Company is a full range solution provider for bedding and allied products. It operates strong Comforr Centres as one stop shop for discerning consumers, including baby products The quality products across its subsidiaries provide multiple choice for its different classes of consumers.

“Vitapur Nigeria Limited manufactures insulation boards, and sandwich panels amongst others, Vitavisco  produces elastic foam, pillow, and foam sheet used for construction, Vono produces metal and wood furniture, Vitablom and  the new baby,  Vitapart are into oil filtering production, the first of its type in the West Africa. Vitafoam group has factories in Kano, Jos, Aba, and Ikeja as well as offshores,”,  Adeniyi said.

After the facilities tour, the President, OTACCWA, Mr Alexander Isong commended the Management of Vitapur for the state-of -the -art factory, saying  “ it  meets standard and the management should support the vibrant staff at the laboratory line”

Continue Reading

Business News

Four banks borrow $6.21bn from foreign market amid dollar shortage

Published

on


In a bid to support their balance sheets with foreign exchange, four banks in the country raised $6.21bn from foreign creditors between January and October 2021.

An analysis of reports shared on the issuer’s portal of the Nigerian Exchange Limited revealed that Access Bank Plc, Ecobank Transnational Incorporated, Fidelity Bank Plc and the United Bank for Africa Plc sought dollar liquidity through secure and unsecured notes, three of which listed their notes on the London Stock Exchange.

On February 11, Ecobank notified the NGX of successful pricing of its $300m fixed-rate, dollar-denominated bond, carrying a coupon rate of 7.125 per cent. It said the issuance was oversubscribed three times, with about $900m raised.

The rating of B- from Fitch Ratings hinted that the bank was more vulnerable to adverse business, financial and economic conditions but could meet its financial commitments as of the time of issuance.

The bank also announced a $350m tier 2 sustainability Eurobond raise in July issued with a coupon of 8.75 per cent, which was oversubscribed 3.6x, amounting to $1.3bn at its peak.

Access Bank, as part of its expansion drive, raised two tranches of Eurobonds in September.

Its $500m senior unsecured Eurobond rated B by Fitch Ratings and B2 negative outlook by Moody’s showed there was a high credit risk and vulnerability to adverse business, financial and economic conditions, but with a capacity to meet financial obligations.

The bank said the senior unsecured five-year Eurobond with a 6.125 per cent coupon was three times oversubscribed, ending over $1.6bn at the end of the transaction. It also completed another $500m offering with a 9.125 per cent coupon oversubscribed by 200 per cent, peaking at over $1bn.

This month, UBA announced its $300m senior unsecured Eurobond issued at a coupon of 6.75 per cent. The notes, rated B by Fitch and B- by S&P Global Ratings, showed a vulnerability to adverse business, financial and economic conditions.

Fidelity Bank, in October, raised $400m through a five-year tenor Eurobond with a 7.765 per cent coupon, listed on the Irish Stock Exchange.

Analysts told The PUNCH that the banks sought funding from the international markets to support dollar-needing opportunities, equity positions on their balance sheets, and mitigation of risks posed by the devaluation of the naira.

A financial analyst, Kalu Aja, said that since banks provided dollars needed for the importation of goods into the country, acquiring funding from the international market was a necessity.

A research analyst, Adedayo Bakare, said, “Ecobank and Access Bank, for example, are using part of the funds to refinance existing assets.

“Part of Access Bank’s raise was used to pay off investors for its bond that matured in October 2021. Some of it will also be used to fund its leveraged expansion drive.”

Industry watchers have raised concerns that the budget deficit funding requirements of the Federal Government had resulted in crowding out of the private sector from the local capital market.

Continue Reading
Advertisement

Facebook

Recent Posts

Advertisement
Advertisement

Trending News

Trending